Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-055918

Chief Operating Officer bought 2,500 shares at $4.62 ($11,559)

From the SEC's structured data for this filing

Trades in this filing

Discordia Robert Paul · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-11-11 Purchase : show line 1 in the form +2,500 $4.62 $11,559 32,650 D
Open-market purchases · 2,500 sh · avg $4.62 · $11,559
Loading xslF345X03/doc4.xml…